Moreover, overexpression and knockdown of SOX9 were performed through an overexpression plasmid in the human colorectal carcinoma cell lines Caco-2 and DLD-1 and through siRNA in HCT116 and HT-29 cells, respectively (Fig. 5e and f). This evidence concerns the gene SOX9 and colorectal carcinoma.